Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
at www.benzinga.com (Wed, 24-Apr 2:23 PM)
Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings
at www.benzinga.com (Wed, 24-Apr 12:12 PM)
at www.tipranks.com (Wed, 24-Apr 9:10 AM)
Biogen says uptake for Alzheimer’s therapy is improving
at seekingalpha.com (Wed, 24-Apr 8:03 AM)
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and BioMarin Pharmaceutical (BMRN)
at www.tipranks.com (Wed, 24-Apr 8:00 AM)
Biogen Non-GAAP EPS of $3.67 beats by $0.21, revenue of $2.29B misses by $30M
at seekingalpha.com (Wed, 24-Apr 6:51 AM)
at www.tipranks.com (Wed, 24-Apr 5:42 AM)
at www.tipranks.com (Wed, 24-Apr 5:28 AM)
Biogen Q1 2024 Earnings Preview
at seekingalpha.com (Tue, 23-Apr 11:01 AM)
Notable earnings before Wednesday's open
at seekingalpha.com (Tue, 23-Apr 10:25 AM)
at www.tipranks.com (Tue, 23-Apr 5:19 AM)
Top high growth investment ratio stocks from each sector - GS
at seekingalpha.com (Mon, 22-Apr 4:25 PM)